Experience from the first UK inter-regional specialist multidisciplinary meeting in the diagnosis and management of IgG4-related disease.
Journal article
Goodchild G. et al, (2020), Clin med (lond), 20, e32 - e39
Early development of new cardiovascular risk factors in the systemic vasculitides.
Journal article
Monti S. et al, (2020), Clin exp rheumatol, 38 Suppl 124, 126 - 134
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.
Journal article
Hellmich B. et al, (2020), Ann rheum dis, 79, 19 - 30
Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitides: Insights from the DCVAS study.
Journal article
Bischof A. et al, (2019), Neurol neuroimmunol neuroinflamm, 6
Rheumatoid factor testing in Spanish primary care: A population-based cohort study including 4.8 million subjects and almost half a million measurements.
Journal article
Morsley K. et al, (2019), Reumatol clin, 15, 350 - 354
Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Journal article
Gibson KM. et al, (2019), Arthritis rheumatol, 71, 1747 - 1755
Patterns of Arterial Disease in Takayasu's Arteritis and Giant Cell Arteritis.
Journal article
Gribbons KB. et al, (2019), Arthritis care res (hoboken)
Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic Vasculitis.
Journal article
Tomasson G. et al, (2019), J rheumatol, 46, 928 - 934
Giant cell arteritis: new concepts, treatments and the unmet need that remains.
Journal article
Coath F. et al, (2019), Rheumatology (oxford), 58, 1123 - 1125
Giant cell arteritis: new concepts, treatments and the unmet need that remains.
Journal article
Coath F. et al, (2019), Rheumatology (oxford), 58
A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN THE TREATMENT OF PATIENTS WITH GIANT CELL ARTERITIS
Conference paper
Schmidt W. et al, (2019), Annals of the rheumatic diseases, 78, 827 - 827
Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study.
Journal article
Jayne D. et al, (2019), Arthritis rheumatol, 71, 952 - 963
HOW TO ASSESS PATIENT WITH SUSPECTED VASCULITIS
Conference paper
Luqmani R., (2019), Annals of the rheumatic diseases, 78, 36 - 37
MANAGEMENT OF TAKAYASU ARTERITIS: A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2018 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF LARGE VESSEL VASCULITIS
Conference paper
Agueda AF. et al, (2019), Annals of the rheumatic diseases, 78, 421 - 422
RESULTS OF A SYSTEMATIC LITERATURE REVIEW INFORMING THE 2018 UPDATE OF THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF LARGE VESSEL VASCULITIS: EVIDENCE TO GUIDE THE MANAGEMENT OF GIANT CELL ARTERITIS
Conference paper
Monti S. et al, (2019), Annals of the rheumatic diseases, 78, 823 - 823
SELF-MANAGEMENT BEHAVIOURS IN ANCA-ASSOCIATED VASCULITIS: SECONDARY ANALYSIS OF INTERVIEW DATA
Conference paper
Reynolds T. et al, (2019), Annals of the rheumatic diseases, 78, 1764 - 1765
THE IMPACT OF DISEASE EXTENT AND SEVERITY DETECTED BY QUANTITATIVE ULTRASOUND ANALYSIS IN THE DIAGNOSIS AND OUTCOME OF GIANT CELL ARTERITIS: RESULTS FROM THE TEMPORAL ARTERYBIOPSY VERSUS ULTRASOUND (TABUL) STUDY AND VALIDATION IN AN INDEPENDENT COHORT
Conference paper
Monti S. et al, (2019), Annals of the rheumatic diseases, 78, 146 - 147
WIN: VASCULITIS MAINTENANCE TREATMENT
Conference paper
Luqmani R., (2019), Annals of the rheumatic diseases, 78, 13 - 13
Prevalence and Associations of Peripheral Neuropathy at Disease Onset in ANCA-Associated Vasculitides: Insights from the DCVAS Study
Conference paper
Bischof A. et al, (2019), Neurology, 92
A computerised system to evaluate patients with rheumatic diseases.
Journal article
Luqmani R. et al, (2019), Future healthc j, 6, 80 - 81